Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALStandard

ALORA

ESTRADIOL

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ALORA is listed in Drugs@FDA under application 021310 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL Form and strength FILM, EXTENDED RELEASE; TRANSDERMAL - N/A Sponsor WATSON LABS Submission history Latest submission status date: 2002-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALORA is listed in Drugs@FDA under application 021310 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL Form and strength FILM, EXTENDED RELEASE; TRANSDERMAL - N/A Sponsor WATSON LABS Submission history Latest submission status date: 2002-04-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.